Home Regeneron skids on shortfall in Eylea sales
 

Keywords :   


Regeneron skids on shortfall in Eylea sales

2014-11-05 00:27:56| Biotech - Topix.net

Regeneron Pharmaceuticals Inc. tumbled by more than $21 a share in morning trade Tuesday after the drug maker surprised investors with disappointing sales of a key product and reported third-quarter earnings that fell below forecasts. stumbled from grace as analysts said some of the air appears to be seeping from expectations for the company's blockbuster eye drug, Eylea.

Tags: sales shortfall skids regeneron

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
29.09When to recline and how to share armrests: Rules for avoiding a mid-flight row
29.09Atlantic Tropical Weather Outlook
29.09Eastern North Pacific Tropical Weather Outlook
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 12
28.09Tropical Storm Joyce Graphics
28.09Hurricane Isaac Wind Speed Probabilities Number 12
28.09Hurricane Isaac Forecast Advisory Number 12
More »